Global Director Real World Evidence (m/f/x)

Apply now »

Date: 06-Oct-2020

Location: Munich, Germany, 81379

Company: Daiichi Sankyo Europe

Affiliate: Daiichi Sankyo Europe GmbH



Passion for Innovation. Compassion for Patients.™

Daiichi Sankyo and its 15.000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology. Our European headquarters are in Munich, Germany and we have affiliates in 13 European countries including Denmark, where Copenhagen acts as the Nordic headquarter. For more information:



We are seeking highly qualified candidates to fill the position of


Global Director Real World Evidence (m/f/x)



Purpose of the function:

The Global Director RWE will lead the RWE implementation and evidence generation for a successful market access and HEOR strategy across Daiichi-Sankyo. He/She will coordinate the use of RWD and RWE under the Global Market Access & Pricing department in collaboration with cross-functional teams. The role will be responsible for the RWE implementation and RWD acquision plan for the department and propose innovative tools, methods, and advanced analytics for RWE to support the company’s vision and improved patient access to Daiichi Sankyo products.



Reports directly to the Vice President and Global Head of RWE, RWD, & Analytics and has the responsibility to build a robust RWE/RWD plan and manage the appropriate resources to make the vision come to life for Daiichi Sankyo. The position will be a key and visible expert leader, he/she will engage the clinical, Medical Affairs and commercial organization in increasing awareness of RWD & RWE, contributing to product evidence strategies, and effective use of RWD & RWE. 


Role and Responsibilities:

The Global Director of RWE will have responsibility and accountability for the following:  

  • Develop and execute global strategies for the acquisition and use of RWD to support and enhance the market access strategies
  • Optimally leverage RWE, RWD, and advanced analytics for RWE and HEOR projects
  • Propose and drive innovative advances in Daiichi-Sankyo capabilities in data management and analysis by educating stakeholders about the uses, applications, benefits and value of Real World Data & Real World Evidence
  • Assist and educate members of the RWE/HEOR, and Access teams to ensure they have the necessary skills, capabilities and experiences to deliver industry-leading RWE analyses and insights
  • Ensure cross-functional collaboration between Global Market Access and Pricing and other internal stakeholders such as Medical Affairs, Clinical Development, Marketing, Biostats, etc.
  • Development and ongoing revision of strategic plans for RWE and RWD and support the HEOR team in the annual brand planning 
  • Propose and execute strategic development projects related to identification, acquisition, analysis, and dissemination of RWD working closely with key stakeholders across the organization
  • Leading the search of new RWD sources and establishing partnerships with relevant data custodians/providers, RWE vendors, and healthcare organisations


Personal skills and professional experience:

  • Advanced degree in epidemiology, biostatistics, and/or health economics (PhD, MD, MSc, or Pharm D degree). Minimum of 5-10 years of experience in managing and working with large volumes of RWD & RWE in different regions, preferably with training and on-the-job experience in any of the area’s epidemiology, biostatistics, and health economics
  • Experience within a pharmaceutical industry, consulting, or equivalent organization involved in research and development of healthcare technologies and/or delivery solutions
  • Experience with strategic and operating planning processes with strong interpersonal skills and evidence of both leadership and team-working in a matrix environment, experience from R&D and/or RWE in oncology is an advantage
  • Knowledge and understanding of pharmaceutical commercial activities, research and development, and clinical research/trials
  • Strong technical knowledge of epidemiological methods, biostatistics/analytics, and RWE study design and execution, with experience in areas such as design and implementation of external control arms to support clinical trials, acquisition and advanced analytics of EMR data, and reporting/publishing of observational research
  • Proven track record of RWE study design and execution, RWD acquisition and analytics, and dissemination of scientific research
  • Proven ability to work cross-functionally, build coalitions and develop strong partnerships across functions
  • Outstanding writing and presentation skills and ability to work under pressure, to take accountability for business challenges, think strategically and tackle complex problems
  • Intellectual curiosity and ability to identify trends and emerging patters in areas such as RWE, HEOR, HTA assessments, Market Access, and Healthcare delivery and payer requirements
  • Personal values matching Daiichi-Sankyo values: integrity, collaboration, commitment and courage are our basic values for the day-to-day interactions with customers and colleagues



What we offer:


We offer an interesting, diversified and challenging position, good contractual conditions, flexible working models, all the social benefits of a modern company and a professional environment where you will have the opportunity for personal growth.


Please apply online at our Career Portal. We are looking foward to hearing from you.